Mastoiditis primary prevention

Revision as of 22:39, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mastoiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mastoiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Mehrian Jafarizade, M.D [2]

Overview

Preventing mastoiditis primarily involves preventing development of otitis media and nasopharyngitis. This is achieved by administration of the pneumococcal and influenza vaccines, frequent washing of hands, and avoiding fluid transmission and respiratory droplets from nasopharyngitis patients. Preventing exposure to air pollution and potential middle ear irritants, such as secondhand smoke, helps prevent otitis media. For infants, preventive measures include avoiding pacifiers, avoiding daycare enrollment, and breastfeeding until at least 6 months of age. A prophylactic regimen of antibiotics can prevent otitis media in at-risk infants and children.

Primary Prevention

Preventive measures for mastoiditis such as the following involve preventing the development of otitis media and nasopharyngitis from infectious pathogens:

  • Avoid first or secondhand smoke or other air pollutants with potential for middle ear irritation.[2]
  • Avoid use of pacifiers in infants.
  • Avoid enrollment in daycare centers.
  • Breastfeed infants until at least 6 months of age[3]

Administering a prophylactic antibiotic regimen for children at risk of developing recurrent otitis media (such as immunosuppressed children or the genetically susceptible):

References

  1. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD, Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE (2013). "The diagnosis and management of acute otitis media". Pediatrics. 131 (3): e964–99. doi:10.1542/peds.2012-3488. PMID 23439909.
  2. "Ear infection - acute: MedlinePlus Medical Encyclopedia".
  3. Sabirov A, Casey JR, Murphy TF, Pichichero ME (2009). "Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6". Pediatr. Res. 66 (5): 565–70. doi:10.1203/PDR.0b013e3181b4f8a6. PMC 2783794. PMID 19581824.
  4. 4.0 4.1 4.2 Leach AJ, Morris PS (2006). "Antibiotics for the prevention of acute and chronic suppurative otitis media in children". Cochrane Database Syst Rev (4): CD004401. doi:10.1002/14651858.CD004401.pub2. PMID 17054203.

Template:WH Template:WS